NCT07215936View on ClinicalTrials.gov

Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 25, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Colorectal Cancer
Interventions
DRUG

Arm A:Dose_dense Capecitabine in Colorectal cancer

Appling dose \_dense Capecitabine 1750mg/m2 for one week then one week off Cycle repeated every 2 weeks

DRUG

Arm B : standard dose Capecitabine

Pateints will receive capecitabine 1000 mg/m2 for 2 weeks then one week off

Trial Locations (1)

Unknown

Sohag university hospital, Sohag

All Listed Sponsors
lead

Sohag University

OTHER